Search 

Therakind, a private European pharmaceutical company, is focused on creating and developing safe, effective, authorised paediatric and speciality niche medicines. Our primary objective is to increase the availability of authorised paediatric and niche medicines and to ensure that the medication used today is both safe and effective.



Therakind's team has extensive experience in the paediatric pharmaceutical sector, we have the expertise to design clinical programmes and regulatory strategy to advance medicines from concept through to regulatory approval.



Therakind was pivotal in the process of bringing Buccolam®, a treatment for prolonged acute convulsive seizures, to the EU market. This product has been sold to Viropharma Inc (now Shire Pharmaceuticals) and is marketed across Europe.



Therakind is a private European pharmaceutical company established in 2006.

Tissue Solutions specializes in sourcing biological material for the global pharma & biotech industry. We are a virtual biobank, working with multiple sources to ethically acquire samples on behalf of our clients for use in preclinical research. We provide access to banked human tissues and set up prospective collections in the UK and USA. We specialise in sourcing difficult to access tissues, eg fresh samples or those with specific inclusion and exclusion criteria. We provide both diseased and non-diseased samples, FFPE and fresh frozen and fresh samples.